StonvexLoading…
StonvexStonvexStonvexCore line items from AVPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $117.24M | $419.50M | $304.81M | $195.08M |
Operating Income | $12.73M | $33.03M | $18.51M | $10.38M |
Net Income | $15.25M | $34.80M | $19.16M | $6.46M |
EPS (Diluted) | $0.07 | $0.15 | $0.08 | $0.03 |
Total Assets | $734.19M | $789.18M | $743.51M | $700.13M |
Total Liabilities | $295.38M | $310.48M | $276.71M | $256.99M |
Cash & Equivalents | $444.13M | $481.06M | $471.64M | $429.82M |
Free Cash Flow OCF − CapEx | $22.98M | $81.57M | $52.61M | $18.29M |
Shares Outstanding | 211.85M | 215.08M | 212.59M | 211.14M |